0001596783-23-000126.txt : 20230901 0001596783-23-000126.hdr.sgml : 20230901 20230901135235 ACCESSION NUMBER: 0001596783-23-000126 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230830 FILED AS OF DATE: 20230901 DATE AS OF CHANGE: 20230901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GREISCH JOHN J CENTRAL INDEX KEY: 0001278569 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36587 FILM NUMBER: 231231935 MAIL ADDRESS: STREET 1: C/O CATALENT, INC. STREET 2: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Catalent, Inc. CENTRAL INDEX KEY: 0001596783 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208737688 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 BUSINESS PHONE: (732) 537-6200 MAIL ADDRESS: STREET 1: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 FORMER COMPANY: FORMER CONFORMED NAME: PTS Holdings Corp. DATE OF NAME CHANGE: 20140113 4 1 wf-form4_169359074262075.xml FORM 4 X0508 4 2023-08-30 0 0001596783 Catalent, Inc. CTLT 0001278569 GREISCH JOHN J C/O CATALENT, INC. 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 1 1 0 0 Executive Chair 0 Common Stock 16196 D Common Stock 2023-08-30 4 P 0 21000 50.24 A 34000 I Through John J. Greisch 2014 Trust Options to purchase Common Stock 48.98 2023-08-30 4 A 0 127096 0 A 2033-08-30 Common Stock 127096.0 127096 D The number of securities reported reflects the forfeiture of 684 restricted stock units granted to the reporting person on October 27, 2022 upon the reporting person's appointment as an executive officer of the Issuer. Volume-weighted average price. These shares were purchased in multiple transactions at prices ranging from $49.97 to $50.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. The options vest and become exercisable in four equal annual installments beginning on August 30, 2024. /s/ Amy Fallone, attorney-in-fact 2023-09-01